Relapsed or Refractory Peripheral T Cell Lymphoma
1 competing product in clinical development for Relapsed or Refractory Peripheral T Cell Lymphoma.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mitoxantrone Hydrochloride Liposome & Enlonstobart | Sun Pharmaceutical | Phase 1/2 | Recruiting | 39 |